D. Devanand

Cheng-Sheng Chen, D. Devanand, Hsiu-Fen Lin, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Should Tricyclic Antidepressants or Lithium Be Standard Continuation Treatment After ECT: An Alternative View.

H. Sackeim, J. Prudic, D. Devanand, 1989, Convulsive therapy.

The effects of electroconvulsive therapy on memory of autobiographical and public events.

S H Lisanby, J. H. Maddox, H. Sackeim, 2000, Archives of general psychiatry.

ECT in bipolar and unipolar depression: differences in speed of response.

H. Sackeim, S. Lisanby, J. Prudic, 2001, Bipolar disorders.

Does ECT alter brain structure?

H. Sackeim, A. Dwork, T. Bolwig, 1994, The American journal of psychiatry.

Does ECT permanently alter seizure threshold?

H. Sackeim, J. Prudic, D. Devanand, 1993, Biological Psychiatry.

The Relative Efficiency of Altering Pulse Frequency or Train Duration When Determining Seizure Threshold

H. Sackeim, S. Lisanby, D. Devanand, 1998, The journal of ECT.

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode

H. Sackeim, B. Mulsant, J. Prudic, 2020, Brain Stimulation.

Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement.

H. Sackeim, D. Devanand, 1992, General hospital psychiatry.

Subjective side effects during electroconvulsive therapy.

H. Sackeim, J. Prudic, D. Devanand, 1995, Convulsive therapy.

ECT in a patient with aortic aneurysm.

H. Sackeim, D. Devanand, S. Malitz, 1990, The Journal of clinical psychiatry.

Seizure Elicitation Blocked by Pretreatment with Lidocaine.

H. Sackeim, D. Devanand, 1988, Convulsive therapy.

Effects of electroconvulsive therapy on plasma vasopressin and oxytocin

H. Sackeim, T. Cooper, S. Lisanby, 1998, Biological Psychiatry.

Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease.

J R Moeller, H. Sackeim, R. Mayeux, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.

A. Palmeri, L. Honig, O. Arancio, 2018, Journal of Alzheimer's disease : JAD.

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation

David M. Shade, J. Yesavage, L. Schneider, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

Pica in the Geriatric Mentally Ill: Unrelenting and Potentially Fatal

D. Devanand, N. Dumaguing, I. Singh, 2003, Journal of geriatric psychiatry and neurology.

Effects of major depression on estimates of intelligence.

H. Sackeim, J. Prudic, D. Devanand, 1992, Journal of clinical and experimental neuropsychology.

Subjective Side Effects Acutely Following ECT: Associations with Treatment Modality and Clinical Response.

H. Sackeim, D. Devanand, N. Hopkins, 1987, Convulsive therapy.

Lithium treatment and risk for dementia in adults with bipolar disorder: Population-based cohort study

M. Olfson, S. Crystal, D. Devanand, 2015, British Journal of Psychiatry.

Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life.

B. Lebowitz, K. Krishnan, M. Weissman, 2003, Archives of general psychiatry.

The course of psychopathologic features in mild to moderate Alzheimer disease.

M. Albert, K. Marder, J. Brandt, 1997, Archives of general psychiatry.

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

R. Mayeux, Y. Stern, M. Sano, 1996, Archives of general psychiatry.

Who Responds to Electroconvulsive Therapy?

H. Sackeim, J. Prudic, D. Devanand, 1996, British Journal of Psychiatry.

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease

M. Albert, K. Marder, J. Brandt, 1994, Neurology.

Late Onset Mania

D. Devanand, D. Birkett, Asif Habib, 1998 .

Myoclonus during combined tricyclic antidepressant and lithium treatment.

H. Sackeim, D. Devanand, R. Brown, 1988, Journal of clinical psychopharmacology.

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis

G. Small, A. Atri, J. Susman, 2021, Journal of internal medicine.

Spatial Registration Evaluation of [18F]-MK6240 PET

James Zou, Adam M. Brickman, Aubrey Johnson, 2020, 2010.07897.

A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease

K. Marder, R. Mayeux, Y. Stern, 1996, Neurology.

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population

A. Brickman, R. Mayeux, Y. Stern, 2015, PloS one.

The development of mania and organic euphoria during ECT.

H. Sackeim, J. Prudic, D. Devanand, 1988, The Journal of clinical psychiatry.

The differential impact of unique behavioral and psychological symptoms for the dementia caregiver: how and why do patients' individual symptom clusters impact caregiver depressive symptoms?

Y. Stern, D. Devanand, J. Gaugler, 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Are there sensitive time periods for dementia caregivers? The occurrence of behavioral and psychological symptoms in the early stages of dementia

Y. Stern, N. Scarmeas, D. Devanand, 2013, International Psychogeriatrics.

Absence of cognitive impairment after more than 100 lifetime ECT treatments.

H. Sackeim, D. Devanand, A. Verma, 1991, The American journal of psychiatry.

Subjective memory complaints prior to and following electroconvulsive therapy

H. Sackeim, J. Prudic, D. Devanand, 1996, Biological Psychiatry.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

David M. Shade, J. Yesavage, L. Schneider, 2015, International Psychogeriatrics.

Depressive symptoms, vascular risk factors, and Alzheimer's disease

L. Honig, J. Luchsinger, M. Tang, 2008, International journal of geriatric psychiatry.

Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.

Corinne E. Fischer, D. Jeste, M. Sano, 2019, Journal of Alzheimer's disease : JAD.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.

David M. Shade, J. Yesavage, L. Schneider, 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

An open trial of aripiprazole augmentation for SSRI non‐remitters with late‐life depression

H. Sackeim, D. Devanand, S. Roose, 2007, International journal of geriatric psychiatry.

Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease

M. Albert, K. Marder, J. Brandt, 2002, Neurology.

Predicting time to nursing home care and death in individuals with Alzheimer disease.

M. Albert, W. Tsai, K. Marder, 1997, JAMA.

Treatment of behavioral and psychological symptoms in dementia

B. Lawlor, D. Devanand, 2000 .

A Feasibility Study of a New Method for Electrically Producing Seizures in Man: Focal Electrically Administered Seizure Therapy [FEAST]

Sarah H. Lisanby, Mark S. George, Joan Prudic, 2013, Brain Stimulation.

Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol.

K. Marder, G. Pelton, T. Cooper, 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.

David M. Shade, J. Yesavage, L. Schneider, 2016, British journal of clinical pharmacology.

Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.

David M. Shade, J. Yesavage, L. Schneider, 2016, The American journal of psychiatry.

EffectofCitalopramonAgitationinAlzheimerDisease The CitAD Randomized Clinical Trial

David M. Shade, J. Yesavage, L. Schneider, 2014 .

Electroconvulsive therapy in the elderly

D. Devanand, R. Krueger, 1994 .

Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis.

K. Marder, Y. Stern, G. Pelton, 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Mild Parkinsonian signs are associated with lower olfactory test scores in the community‐dwelling elderly

K. Marder, M. Tabert, D. Devanand, 2008, Movement disorders : official journal of the Movement Disorder Society.

Focal Prefrontal Seizures Induced by Bilateral ECT

H. Sackeim, S. Lisanby, J. Prudic, 2001, The journal of ECT.

The Columbia University Scale for Psychopathology in Alzheimer's disease.

K. Marder, R. Mayeux, Y. Stern, 1992, Archives of neurology.

Deep learning improves utility of tau PET in the study of Alzheimer's disease

A. Brickman, J. Luchsinger, D. Devanand, 2021, Alzheimer's & dementia.

A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease.

M. Albert, K. Marder, M. Sano, 1995, Archives of neurology.

Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center.

K. Marder, R. Mayeux, Y. Stern, 2012, Journal of Alzheimer's disease : JAD.

Predictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment

Y. Stern, M. Sano, G. Pelton, 2010, Dementia and Geriatric Cognitive Disorders.

The relations between observer-rating and self-report of depressive symptomatology.

Nina A. Sayer, H. Sackeim, J. Moeller, 1993 .

The impact of mild cognitive impairment on functional abilities in the elderly

G. Pelton, S. Albert, D. Devanand, 2002, Current psychiatry reports.

Evaluation of CT Imaging Features in Predicting Clinical Outcome in Moderate to Severe Traumatic Brain Injury

D. Devanand, D. Arunkumar, Dr. Vikrant Kanagaraju, 2016 .

Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.

A. Palmeri, L. Honig, O. Arancio, 2019, Journal of Alzheimer's disease : JAD.

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

Curtis L. Meinert, Bruce G. Pollock, Daniel Weintraub, 2014, Alzheimer's & Dementia.

Delusions and patterns of cognitive impairment in Alzheimer's disease

M. Albert, M. Folstein, Y. Stern, 1994 .

Erratum: Multicenter study of predictors of disease course in Alzheimer disease (the 'predictors study'). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity (Alzheimer Disease and Associated Disorders (1993) 7 (22-32))

M. Albert, M. Folstein, K. Marder, 1993 .

Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). II. Neurological, Psychiatric, and Demographic Influences on Baseline Measures of Disease Severity

M. Albert, M. Folstein, K. Marder, 1993, Alzheimer disease and associated disorders.

An open trial of venlafaxine for the treatment of late‐life atypical depression

H. Sackeim, D. Devanand, S. Roose, 2004, International journal of geriatric psychiatry.

Consensus provisional definition of agitation in cognitive disorders

C. Lyketsos, M. Sano, J. Cummings, 2019, Definitions.

Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World

Kaylee A. Bodner, T. Goldberg, P. Doraiswamy, 2020, Frontiers in Psychiatry.

Longitudinal study of quality of life in people with advanced Alzheimer's disease.

M. Albert, K. Marder, J. Brandt, 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The efficacy of ECT in double depression

H. Sackeim, J. Prudic, D. Devanand, 1993 .

Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls

R. V. Van Heertum, J. Mann, R. Parsey, 2010, Journal of geriatric psychiatry and neurology.

Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease.

D. Devanand, D. Devanand, Xinhua Liu, 2011, Archives of general psychiatry.

Hippocampal and entorhinal atrophy in mild cognitive impairment

R. Mayeux, Y. Stern, M. J. Leon, 2007, Neurology.

Is dysthymia a different disorder in the elderly?

H. Sackeim, D. Devanand, M. Nobler, 1994, The American journal of psychiatry.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Sara Rosenblum, Yaakov Stern, Y. Stern, 2006, Archives of general psychiatry.

Frailty and depression in older adults: a high-risk clinical population.

D. Devanand, T. Rantanen, D. Devanand, 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Comparative mortality risks of antipsychotic medications in community-dwelling older adults.

K. Huybrechts, S. Schneeweiss, M. Olfson, 2014, The British journal of psychiatry : the journal of mental science.

Cardiovascular complications of ECT in depressed patients with cardiac disease.

H. Sackeim, D. Devanand, S. Roose, 1993, The American journal of psychiatry.

Agitation and impulsivity in mid and late life as possible risk markers for incident dementia

S. Gauthier, D. Devanand, C. Ballard, 2020, Alzheimer's & dementia.

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.

H. Sackeim, K. Marder, R. Mayeux, 1998, The American journal of psychiatry.

Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.

H. Sackeim, D. Devanand, G. Pelton, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Acute cognitive effects of subconvulsive electrical stimulation.

H. Sackeim, J. Prudic, D. Devanand, 1994, Convulsive therapy.

The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.

D. Devanand, G. Pelton, H. Andrews, 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Depression in the first year of stay for elderly long-term nursing home residents in the U.S.A.

D. Devanand, S. Crystal, D. Devanand, 2010, International Psychogeriatrics.

Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

Y. Stern, D. Devanand, D. Devanand, 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Electroconvulsive therapy in the treatment-resistant patient.

H. Sackeim, J. Prudic, D. Devanand, 1991, The Psychiatric clinics of North America.

Relapse risk after discontinuation of risperidone in Alzheimer's disease.

D. Devanand, G. Pelton, H. Andrews, 2012, The New England journal of medicine.

False-positive dexamethasone suppression test results related to antipsychotic drug withdrawal: case report.

D. Devanand, M. Dewan, A. Pandurangi, 1984, The Journal of clinical psychiatry.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

R. Mayeux, Y. Stern, D. Devanand, 2005, Archives of neurology.

Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

K. Marder, R. Mayeux, Y. Stern, 2000, The American journal of psychiatry.

Advancing computerized cognitive training for early Alzheimer's disease in a Covid-19 pandemic and post-pandemic world

Kaylee A. Bodner, Terry E. Goldberg, D. P. Devanand, 2020, 2004.14344.

The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease

K. Marder, Y. Stern, G. Pelton, 2009, International journal of geriatric psychiatry.

Discontinuation of risperidone in Alzheimer's disease.

D. Devanand, D. Devanand, S. Schultz, 2013, The New England journal of medicine.

A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.

H. Sackeim, S. Lisanby, J. Prudic, 2000, Archives of general psychiatry.

Psychosis, behavioral disturbance, and the use of neuroleptics in dementia.

H. Sackeim, R. Mayeux, D. Devanand, 1988, Comprehensive psychiatry.

A Feasibility Study of a New Method for Electrically Producing Seizures in Man: Focal Electrically Administered Seizure Therapy [FEAST]

H. Sackeim, Z. Nahas, M. George, 2013, Brain Stimulation.

Sertraline treatment of elderly patients with depression and cognitive impairment

H. Sackeim, Y. Stern, G. Pelton, 2003, International journal of geriatric psychiatry.

Behavioral Syndromes in Alzheimer's Disease

H. Sackeim, R. Mayeux, J. Endicott, 1992, International Psychogeriatrics.

Personality disorders in elderly patients with dysthymic disorder.

D. Devanand, M. Nobler, S. Roose, 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

A 6‐month, randomized, double‐blind, placebo‐controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

H. Sackeim, K. Marder, D. Devanand, 2011, International journal of geriatric psychiatry.

Stroke, Depression, and Functional Health Outcomes Among Adults in the Community

D. Devanand, R. Goodwin, 2008, Journal of geriatric psychiatry and neurology.

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial

Y. Stern, D. Devanand, G. Pelton, 2020, BMJ Open.

Combined treatment with memantine/es‐citalopram for older depressed patients with cognitive impairment: a pilot study

K. Marder, D. Devanand, G. Pelton, 2016, International journal of geriatric psychiatry.

Psychopathological Features in Alzheimer's Disease: Course and Relationship with Cognitive Status

Yaakov Stern, Karen Marder, Jason Brandt, 2003, Journal of the American Geriatrics Society.

Cognitive Enhancers and Treatments for Alzheimer's Disease

D. Devanand, D. Devanand, 2015 .

Advancing computerized cognitive training for early Alzheimer's disease in a pandemic and post-pandemic world pdf

Kaylee A. Bodner, Terry E. Goldberg, D. P. Devanand, 2020, ArXiv.

Advancing computerized cognitive training for early Alzheimer's disease in a Covid-19 pandemic and post-pandemic world

Kaylee A. Bodner, T. Goldberg, P. Doraiswamy, 2020 .

Questionable Dementia: Clinical Course and Predictors of Outcome

Yaakov Stern, James R. Moeller, Davangere P. Devanand, 1997, Journal of the American Geriatrics Society.

Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.

J. Petrella, P. Doraiswamy, G. Pelton, 2014, Contemporary clinical trials.

Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies

T. Goldberg, D. Devanand, E. Huey, 2020, Nature Communications.

Low testosterone levels in elderly men with dysthymic disorder.

D. Devanand, A. Araujo, J. Mckinlay, 2002, The American journal of psychiatry.

Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.

D. Devanand, G. Pelton, D. Devanand, 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.

D. Devanand, D. Devanand, 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Olfactory Dysfunction in the Elderly: Basic Circuitry and Alterations with Normal Aging and Alzheimer’s Disease

A. Masurkar, D. Devanand, Arjun V. Masurkar, 2014, Current Geriatrics Reports.

Olfactory identification deficits in older adults, cognitive decline and dementia

D. Devanand, D. Devanand, 2016 .

(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.

R. V. Van Heertum, J. Mann, Y. Stern, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Life-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel Recommendations.

É. Bayen, D. Devanand, I. Leroi, 2023, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Dysthymic disorder in the elderly population

D. Devanand, 2013, International Psychogeriatrics.

An Open Treatment Trial of Venlafaxine for Elderly Patients With Dysthymic Disorder

H. Sackeim, D. Devanand, D. Devanand, 2004, Journal of geriatric psychiatry and neurology.

Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients.

H. Sackeim, D. Devanand, G. Pelton, 2004, Journal of affective disorders.

Assessment of late life depression

J. Olin, B. Cuthbert, B. Mulsant, 2002, Biological Psychiatry.